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ABSTRACT:
Opioid-induced respiratory depression (OIRD) is the primary cause of death from opioid
overdose. Opioids depress breathing by diminishing the wakefulness stimulus for breathing in
humans and mice. Cholinergic transmission in the prefrontal cortex (PFC) promotes cortical
EEG activation, increases wakefulness, and stimulates breathing. However, no previous studies
have tested whether increasing cholinergic transmission in the PFC can mitigate respiratory
depression caused by systemically administered fentanyl in mice. The series of studies
comprising this honors thesis is split into two phases. The first phase included a concentration
response study evaluating the effects of fentanyl on breathing in C57BL/6J mice breathing room
air. Adult male mice (n = 12) received intraperitoneal (IP) injections of saline and fentanyl in
increasing half log unit doses. The second phase tested the hypothesis that microinjection of the
acetylcholinesterase inhibitor neostigmine into the PFC attenuates OIRD caused by systemic
fentanyl administration in male B6 mice. Adult male mice (n = 4) were surgically implanted with
microinjection guide tubes aimed at the medial prefrontal cortex. Subjects were given a systemic
injection of either saline or fentanyl, followed by a microinjection of saline or neostigmine.
Preliminary data show that neostigmine mitigated the effects of fentanyl on breathing and
significantly slowed the onset of OIRD. Histology pending, these results support the
interpretation that cholinergic transmission in the PFC contributes to the wakefulness stimulus
for breathing, extend previous data showing that breathing is stimulated by PFC neostigmine,
and demonstrate that enhancing PFC cholinergic transmission offsets OIRD caused by
systemically administered fentanyl.
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INTRODUCTION:
Opioids are analgesics commonly prescribed for chronic and post-operative pain
treatment but bring a multitude of unwanted side effects, namely respiratory depression. Opioidinduced respiratory depression (OIRD) is the primary cause of death from opioid overdose and
limits the clinical efficacy of opioids (K. T. Pattinson, 2008). Deaths involving synthetic opioids
have increased by 1040% from 2013 to 2019 (Mattson et al., 2021), contributing to the ongoing
opioid epidemic. In the clinical setting, patients with OIRD place a great financial burden on
hospitals (Khanna et al., 2021). These findings illustrate an urgent need for research seeking to
develop safer use of opioids. The National Institutes of Health (NIH) has launched a
comprehensive research initiative to promote evidence-based approaches to treat Opioid Use
Disorder, opioid overdose, and chronic pain (Volkow & Collins, 2017). The studies in my honors
thesis align with these interests of the NIH.
The subject of OIRD is relevant for a psychology honors thesis in two major ways. First,
opioids depress breathing by acting on mu-opioid receptors (A. Dahan et al., 2001) located in the
brainstem respiratory network (Fig. 1). Recent studies have focused on the preBötzinger complex
(preBöt) of the ventrolateral medulla and the parabrachial nucleus (PBN) of the dorsolateral pons
as the brainstem nuclei mediating OIRD (Levitt, Abdala, Paton, Bissonnette, & Williams, 2015;
Montandon et al., 2011; Montandon et al., 2016). The preBöt generates the respiratory rhythm in
mammals, (J. C. Smith, Ellenberger, Ballanyi, Richter, & Feldman, 1991), drives the inspiratory
phase of breathing (J. C. Smith, Abdala, Borgmann, Rybak, & Paton, 2013), and expresses muopioid receptors (Gray, Rekling, Bocchiaro, & Feldman, 1999). In the PBN, the Kölliker-Fuse
(KF) nucleus mediates the transition from the inspiratory to the expiratory phase of breathing and
is crucial for eupneic, or normal, unlabored, breathing (Cohen, 1971; Dutschmann & Herbert,
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2006; Lumsden, 1923). Morphine and fentanyl injections into the preBöt and PBN/KF nuclei
result in increased inspiratory time (Ti), decreased inspiratory airflow, and decreased respiratory
rate (Bachmutsky, Wei, Kish, & Yackle, 2020). These studies emphasize the viewpoint that
breathing is a behavior generated by the brain and can be understood in terms of
neurophysiological mechanisms.
Figure 1. Schematic of the brainstem
respiratory nuclei implicated in OIRD,
including the preBötzinger complex (preBöt) at
the ventrolateral medulla and the Kölliker-Fuse
nuclei at the parabrachial nucleus in the pons.
Respiratory depression from opioids is caused
by activation of mu-opioid receptors in these
nuclei, which then send efferent connections to
the spinal cord. Figure from (Montandon &
Slutsky, 2019).

Page 5 of 40

Wilton Sun

Honors Thesis

4/28/22

Second, studies of OIRD and breathing are relevant to psychology because changes in
breathing are often dependent on behavioral states. Compared to states of wakefulness,
ventilation decreases in slow-wave (NREM) sleep states as well as states of altered
consciousness caused by anesthetics (Hedenstierna & Edmark, 2015), benzodiazepines
(Guilleminault, 1990), alcohol (Block, Hellard, & Slayton, 1986), and opioids. Although the
altered states of consciousness caused by opioids are distinct from states of wakefulness, NREM
sleep, or REM sleep (Montandon & Horner, 2019; O'Brien et al., 2021), the relationship between
behavioral state and slowed breathing suggests that opioids depress breathing by diminishing the
wakefulness stimulus for breathing. The wakefulness stimulus for breathing refers to the arousalpromoting neurons in the cortex that project to the brainstem respiratory center and modulate
breathing. The wakefulness stimulus is vital for behaviors encompassing the volitional control of
breathing such as breath-holding and speech, and it is relevant in the context of OIRD because it
may explain individual differences in susceptibility to OIRD. For example, having an awareness
of respiration or the urge to breathe allows for appropriate compensatory responses that may
mitigate OIRD. A recent study found that opioids can inhibit these cortical regions implicated in
the urge to breathe and awareness (K. T. S. Pattinson et al., 2009). In this study, human subjects
were given instructions for breath-holding and rated on a numerical scale their urge to breathe,
and functional magnetic resonance imaging measured cortical activity in response to breathholding. Following the administration of remifentanil, urge to breathe scores and blood-oxygenlevel-dependent (BOLD) levels in the cortical regions associated with breath-holding control
were lower relative to the control condition. Lower BOLD levels indicate lower activation of
brain regions, and the associated cortical regions include the PFC, periaqueductal gray (PAG),
and the anterior cingulate cortex (ACC). However, the neuronal networks underlying this
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wakefulness stimulus remain poorly understood. These findings support the interpretation that
opioids diminish the wakefulness stimulus for breathing and validate the psychological relevance
of the present studies.
The PFC contains cholinergic receptors that mediate excitatory neurotransmission to the
brain. Given the role of PFC cholinergic transmission in promoting wakefulness, (Baghdoyan &
Lydic, 2012), it is hypothesized that acetylcholine (ACh) in this region contributes to the
wakefulness stimulus for breathing. Activation of muscarinic cholinergic receptors in the PFC
causes behavioral arousal, as quantified by a decrease in slow-wave EEG power and increased
ACh release (Douglas, Baghdoyan, & Lydic, 2002a, 2002b). Modulation of cholinergic
transmission in the PFC restores consciousness in rodents from an anesthetized state,
characterized by increased respiratory frequency (Pal et al., 2018; Parkar et al., 2020).
Additionally, microinjection of the cholinesterase inhibitor neostigmine into the PFC of awake,
freely behaving mice stimulates breathing (Glovak, O'Brien, Sun, Baghdoyan, & Lydic, 2021).
Cholinergic stimulation in the parietal cortex, and noradrenergic stimulation in the PFC did not
result in behavioral arousal (Pal et al., 2018), signifying that the arousal-promoting effects of
ACh are specific to the PFC. The relationship between ACh in the PFC and opioids is
highlighted in the finding that systemically delivered morphine inhibits ACh release in the PFC
(Osman, Baghdoyan, & Lydic, 2005), suggesting that enhancing cholinergic transmission in the
PFC following opioid administration may provide the excitatory neurotransmission needed to
mitigate respiratory depression. Additionally, the evidence presented in these studies supports
the use of EEG as a validated biomarker of behavioral arousal.
The only current available treatment for OIRD, naloxone, has significant limitations that
necessitate efforts to develop new therapeutics. Naloxone was approved by the Food and Drug
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Administration for treatment of opioid overdose in 1971 and is available in intranasal form under
brand names such as NARCAN®. It is an opioid antagonist with high affinity for the mu-opioid
receptor (Trescot, Datta, Lee, & Hansen, 2008), preventing opioid molecules from binding.
However, naloxone has a very short biological half-life of only 65 minutes (Moss & Carlo,
2019). For comparison, the biological half-life of morphine and fentanyl are 2-3 hours and 8-10
hours, respectively (Berkowitz, 1976; Kharasch, 2015). Thus, the short duration of activity of
naloxone also means a short-lived reversal of overdose that may require continuous infusion of
naloxone or risk of relapse of OIRD (Handal, Schauben, & Salamone, 1983). Additionally,
because naloxone is an opioid receptor antagonist, it also antagonizes all opioid effects,
including analgesia. This limitation necessitates patients to re-administer opioids to achieve
analgesia, subsequently increasing the risk for addiction. A novel treatment that can minimize
the risk of or mitigate respiratory depression without compromising analgesia would eliminate
these limitations and advance chronic pain management.
Preclinical and clinical data support the use of cholinergic drugs as a potential
countermeasure for OIRD. The first known study to successfully reverse OIRD was conducted in
1980, where intravenous administration of the cholinesterase inhibitor physostigmine, but not
neostigmine, antagonized morphine-induced respiratory depression in rabbits and anesthetized
dogs (Weinstock, Roll, Erez, & Bahar, 1980). The differential effects may be attributed to the
properties of neostigmine, which does not cross the blood-brain barrier when delivered
systemically. Opioids also increase the apneic threshold, and this threshold is decreased by
physostigmine (Berkenbosch, Olievier, Wolsink, DeGoede, & Rupreht, 1994). Apneic threshold
refers to the minimum level of carbon dioxide required to maintain normal breathing, and
decreasing the apneic threshold reduces the risk of apnea. Additional studies have found that
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systemic administration of donepezil, which increases endogenous ACh, can rescue respiratory
depression in anesthetized rabbits caused by morphine (Tsujita et al., 2007) and buprenorphine
(Sakuraba et al., 2009). Cholinergic agonists stimulate the rhythm-generating nuclei in the
brainstem in vitro and increase minute ventilation in vivo (Ren, Ding, & Greer, 2019). Although
this honors thesis does not investigate nociception data, the use of cholinergic drugs to prevent
OIRD has the potential to be more versatile than naloxone because it does not antagonize opioidinduced analgesia and may also be beneficial in treating sedation and addiction. Clinical data
show the efficacy of cholinergic drugs in treating opioid-use disorder (Jensen, DeVito, Yip,
Carroll, & Sofuoglu, 2018) and in treating daytime sleepiness and improving nighttime sleep in
patients taking morphine without compromising analgesia (Slatkin, Rhiner, & Bolton, 2001).
Given the relationship between addiction, sedation, and the arousal-promoting effects of the
PFC, these findings strongly suggest that the PFC may be implicated in OIRD. To the best of our
knowledge, there have been no studies testing the effect of cholinergic transmission in the PFC
on OIRD in awake, unrestrained mice.
METHODS:
All procedures in these studies adhere to the Guide for the Care and Use of Laboratory
Animals (National Research Council Committee for the Update of the Guide for the & Use of
Laboratory, 2011) and were reviewed and approved by the University of Tennessee Institutional
Animal Care and Use Committee (IACUC) protocol #2555. The approach to this undergraduate
honors thesis was comprised of two phases. The studies began by deriving direct evidence for the
dose-dependent effects of fentanyl on breathing, providing essential data on the doses of
systemic fentanyl to use in the next phase of experiments. The second phase of experiments
tested whether respiratory depression caused by these systemic doses of fentanyl can be
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prevented with PFC microinjection of neostigmine. All studies use adult male C57BL/6J (B6)
mice purchased from the Jackson Laboratory (Bar Harbor, ME) at 7 weeks of age. Mice were
kept in a 12 hour/12 hour light-dark cycle housing with ad libitum access to food (Tekland 8640
Rodent Diet) and water. Subject health was monitored daily by laboratory personnel.
Measures of breathing (frequency, tidal volume per gram body weight, minute ventilation
per gram body weight, and duty cycle) were quantified by placing mice into whole-body
plethysmography (WBP) chambers (Data Sciences International, USA) at 22° C. The WBP
system permits the collection of data in unrestrained, freely moving mice and minimizes the
effect of animal handling on breathing. Pressure differences are detected by Buxco FinePointe
software and digitalized into the desired respiratory parameters. These techniques used in my
honors thesis are an extension of my independent studies work and involvement in other
respiratory studies in our lab (Glovak et al., 2021).
The DSI PhysioTelTM HD-X02 telemetry system enables the recording of cortical
electroencephalogram EEG and electromyogram EMG signals from mice. Recording electrodes
and the telemeter are implanted in subjects and allow for the collection of data in unrestrained,
freely moving mice. The telemeter sends signal recordings to the data acquisition computer via
DSI receiver pads placed on the bottom of the WBP chambers to permit the simultaneous
recording of breathing and EEG signals. EEG data were collected by DSI Ponemah software and
analyzed using DSI NeuroScore software.
Fentanyl Dose-response Study
These experiments used a within-subjects design in which each mouse (n=12) received a
0.3 mL intraperitoneal (IP) injection of saline and eight doses of fentanyl in increasing
concentrations, separated by one-half log unit (0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1.0, 3.0 mg/kg).
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This design allowed each subject to serve as its own control. These doses have been shown by
preliminary data from our lab to not harm or cause apnea in mice. Injection times occurred
during the same time of day for a maximum of two injection days per week, each day separated
by at least 24 hours to allow subjects to recover. Fentanyl citrate (C28H36N2O8; 528.6 g/mol)
(Sigma-Aldrich, USA) was dissolved in 0.9% saline to yield the desired doses of fentanyl for this
study. Fentanyl does not have an active metabolite (H. S. Smith, 2009), reducing the likelihood
of residual effects of opioid injections from previous days confounding breathing parameters. All
subjects were conditioned to being handled and placed into the WBP chambers for at least two
weeks before data collection. During experiments, subjects were allowed to habituate to the
chambers for at least 30 minutes before an injection was given. The subject was restrained by
hand, the skin over the injection site was cleaned with an alcohol prep pad, and the injection was
given near the intraperitoneal cavity using a 25-gauge luer-lock needle. Breathing data were
collected for 60 minutes post-injection.
Dual Injection Study
All mice (n=4) were surgically implanted with a PlasticsOne 26-gauge intracranial guide
tube to enable in-vivo drug delivery to the PFC and a DSI HD-X02 telemeter for EEG and neck
muscle electromyogram (EMG) recording. Protocols for stereotaxic surgery closely follow the
procedures outlines in previous studies in our lab (O'Brien et al., 2021; Zhang et al., 2020) to
ensure the humane treatment of all subjects during surgery. All surgeries were performed on a
stereotaxic frame (David Kopf Instruments, USA). Isoflurane was the inhaled anesthetic and was
delivered at 2.0% with 100% oxygen at a flow rate of 1 L/min. Loss of righting reflex and paw
withdrawal latency were used as biomarkers for antinociception and the loss of consciousness.
Subject vital signs were continuously monitored throughout the surgery. Isoflurane delivery was
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measured by Datex-Ohmeda Cardiocap5 spectrophotometry system, and concentration
incrementally reduced throughout the surgery to maintain subject respiratory rate above 60
breaths/min. Core body temperature was maintained at 36-37.5°C using Gaymar water pumps
and heating pads. No abnormalities occurred during the surgeries.
An incision was made at the scalp to expose the mouse skull and implant the guide tube.
The guide tube was aimed at the infralimbic cortex (IL) of the PFC at stereotaxic coordinates
A/P = 1.94; M/L = 0.3; D/V = 2.5 relative to bregma (Franklin, 2008). A 1.0 mm craniotomy
was made at this aim point using a 1.0 mm Stoelting drill bit and Foredom K1070 micromotor.
Dental acrylic was applied around the skull and guide tube to keep the guide tube in place and
form a headcap. Additionally, 4 pilot holes were made on the skull with a 0.45 mm Stoelting drill
bit to insert 4 custom Antrin miniature screws. These screws provide an anchor for the guide
tube and headcap.
The HD-X02 telemeter transmitter and accompanying EEG and EMG electrodes were
also implanted during the surgery. The transmitter was implanted near the mouse’s flank by
lengthening the original incision towards the flank and making a subcutaneous pocket. The EMG
electrodes were implanted at the dorsal region of the neck and secured with dental acrylic and
sutures. To implant the EEG electrodes, two 1.0 mm craniotomies were made at stereotaxic
coordinates A/P = 1.0; M/L = -1.0 and A/P = -3; M/L =3.0 relative to bregma. The dental acrylic
from the guide tube head cap kept the electrodes in place. After the surgery, all implanted
subjects were housed singly and given at least seven days to recover from the surgery and adjust
to new housing.
Subjects were conditioned to all experimental procedures for at least 2 weeks before the
start of data collection. These series of experiments used a within-subjects design in which each
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mouse received all three treatment conditions: a saline IP injection followed by a saline
microinjection, a fentanyl IP injection followed by a saline microinjection, and a 0.1 mg/kg
fentanyl IP injection followed by a 0.016 nmol/50nL (4.8 ng/50nL) neostigmine microinjection.
Fentanyl citrate and neostigmine bromide (C12H19BrN2O2; 302.20 g/mol) were dissolved in 0.9%
saline to yield the desired injection concentrations. Before every injection, subjects were placed
in the whole-body plethysmography chambers to acclimate for at least 45 minutes. The IP
injection was performed following the same procedure as the previous dose-response study. The
microinjection apparatus consisted of a micro syringe and a manual drive holding a 1-microliter
Hamilton syringe filled with injection solution, plastic tubing, and a PlasticsOne injector
cannula. To deliver a microinjection, the subject was restrained by its headcap, and the obturator
was removed to place the injector into the guide tube. Injection volume (50 nL) was delivered
evenly over 60 seconds, and the injector was left in the guide tube for 30 seconds post-injection
before removal to prevent suction of injection solution. Due to the small volume of injection,
post-injection flow was measured to confirm delivery of solution by pumping the micro syringe
until fluid was present. The nL until flow was then then recorded as the post-injection flow.
Breathing and EEG were recorded for 60-minutes post-injection. Subjects were monitored during
this recording period and were kept awake by an investigator to prevent any breathing changes
caused by sleep.
Pilot Study: Effects of carbachol microinjected into the prefrontal cortex on breathing and
EEG
Given that neostigmine is an acetylcholinesterase inhibitor that can stimulate breathing
when microinjected into the PFC of awake mice (Glovak et al., 2021), I performed a pilot study
to test whether the same would hold true for a cholinergic drug with a different mechanism of
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action. Carbachol, a mixed cholinergic receptor agonist, was chosen for this purpose. These
experiments used a within subject design in which 3 mice received a 50 nL intracerebral
microinjection of 1mM (9.13 nmol/50nL; 33.36 mg/mL) carbamylcholine chloride
(NH2COOCH2CH2N(Cl)(CH3)3; 182.65 g/mol) and 2 mice received an additional microinjection
of 10 mM (91.3 nmol/50nL; 333.6 mg/mL) carbachol. Subjects used in this study were mice
remaining from the dual injection study. Thus, all microinjection sites and experimental
procedures followed that of previous studies.
Statistical Analysis
All data were analyzed with descriptive, parametric, and nonparametric statistics using
GraphPad Prism 9.2.0. For studies evaluating the dose-dependent effects of fentanyl on
breathing, measures of breathing were expressed as means across 12 subjects over the entire 60minute post-injection recording period. Given that centrally administered drugs rapidly diffuse
away from a microinjection site, measures of breathing for studies evaluating the effect of PFC
neostigmine on fentanyl-induced respiratory depression were expressed as means across 4
subjects during the first 15 minutes post-injection. Analyzing the first 15 minutes provides the
greatest likelihood of inferring the effect of PFC cholinergic transmission on OIRD. For
microinjection studies, raw data are expressed as vertical scatterplots with median and
interquartile range (IQR) bars in accordance with the NIH guidelines for enhancing rigor and
reproducibility in research (https://grants.nih.gov/policy/reproducibility/index.htm). For all
studies, differences in mean across treatment groups were compared using percent change
calculations, and my hypotheses were tested using a repeated measures one-way Analysis of
Variance (ANOVA) with Dunnett’s post-hoc comparisons. The Cohen’s d statistic was
calculated to quantify the relative magnitude of treatment effect. Breathing variability is a
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clinically important biomarker of normal compensatory respiratory response that is compromised
by opioids (Angel et al., 2018). Thus, I also used Poincaré analysis to compare the effects of
fentanyl on breathing variability with and without PFC neostigmine. Finally, regression analyses
were performed to quantify the effects of PFC neostigmine over time.
RESULTS:
Fentanyl Caused Respiratory Depression in B6 Mice in a Dose-dependent Manner
Behavioral observations of the mice were made following administration of each
treatment. All subjects remained awake for the duration of the 60-minute post-injection
recording period. Typical behaviors in the WBP chambers included pacing around the circular
perimeter of the chamber and grooming activity. Measures of frequency and minute ventilation
tended to decrease during the first 20 minutes post-injection, including the saline condition. No
significant phenotypic changes were observed for doses smaller than the 0.3 mg/kg dose.
Beginning with the 0.3 mg/kg dose, mice exhibited the Straub Tail Reaction (STR) effect, which
became more pronounced in the 1.0 mg/kg and 3.0 mg/kg dose. This behavior is characterized as
the tail becoming rigid, erect, and dorsiflexed perpendicular to the rest of the body. The onset of
STR was roughly 2 minutes post-injection. The STR is a well-characterized side effect of
opioids, including fentanyl (Kitanaka et al., 2012; Nath, Gupta, Patnaik, & Dhawan, 1994;
O'Neill, Collins, Pettit, McNutt, & Chang, 1997). Following the administration of the 3.0 mg/kg
dose, mice exhibited disoriented activity. They were unable to pace around the chamber, often
running into and pressing against the plexiglass wall of the chamber, and sometimes remaining
still for minutes. This behavior was not observed in any other treatment condition. Despite these
behaviors, no subjects were at risk of harm to themselves, and all experiments proceeded as
detailed by the protocol.
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Fentanyl caused a significant dose-dependent depression of breathing relative to the
saline condition. Figure 2 shows that frequency and minute ventilation progressively decreased
with higher fentanyl doses. Interestingly, tidal volume and duty cycle progressively increased at
higher doses. On average, the 3.0 mg/kg dose of fentanyl caused a 63.29% decrease in
frequency, 29.24% increase in tidal volume, 55.80% decrease in minute ventilation, and 59.15%
increase in duty cycle. Cohen’s d values for at the 3.0 mg/kg dose signify >95% overlap between
the saline and 3.0 mg/kg distributions: frequency (d = 5.7), tidal volume (d = -2.2), minute
ventilation (d = 3.7), and duty cycle (d = -6.1). It should also be noted that the standard deviation
for F and MvB decreased at the 1.0 mg/kg and 3.0 mg/kg dose (Fig 2), signifying a decrease in
breathing variability. Repeated-measures one-way ANOVA confirmed statistically significant
differences: frequency (F(8,88) = 42.75, P<0.0001), tidal volume (F(3.97, 43.65) = 30.61, p<0.0001),
minute ventilation (F(2.47, 27.12) = 20.30, p<0.0001), and duty cycle (F(2.23, 24.53) = 66.82, p<0.0001).
These values signify a significantly large variance across treatment conditions. Post hoc analyses
revealed that the lowest fentanyl dose causing a significant decrease in frequency and minute
ventilation is 0.01 mg/kg (p=0.02555, p=0.0003, respectively). The half-maximal inhibitory and
effective concentrations of fentanyl (IC50 and EC50) were 0.28 mg/kg for frequency (95% CI
[0.1561, 0.4941]), 0.24 mg/kg for tidal volume (95% CI [0.1096 to 0.5583]), 0.28 mg/kg for
minute ventilation (95% CI [0.1078 to 0.7033]), and 1.63 mg/kg for duty cycle (95% CI [0.9708,
3.098]).
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Figure 2. Fentanyl caused a dose-dependent decrease in breathing. Concentration-response
curves for the effects of fentanyl on frequency (A), tidal volume (B), minute ventilation (C), and
duty cycle (D). Each data point is expressed as means across all subjects for the 60-minute
recording period +/- standard deviation. Data were analyzed using a repeated measures one-way
ANOVA paired with Dunnett’s post hoc tests. Asterisks indicate significant changes in breathing
at a particular dose relative to saline: (*p <0.05, **p<0.01, ***p < 0.002 ****p<0.0001).
Regression analysis showed significant differences in the onset of OIRD between
fentanyl doses. Minute ventilation was chosen for this set of analyses because it serves as the
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aggregate of frequency and tidal volume and is a more comprehensive parameter of oxygenation.
A second-order polynomial regression equation was fitted over time course graphs plotting every
60-second average minute ventilation data point as a function of time over the first 20 minutes
post-injection (Fig 3). Comparison of all model parameters for the 0.03 mg/kg (minute
ventilation = 4.976 - 0.2584(min) + 0.007535(min)2), 0.3 mg/kg (minute ventilation = 4.477 –
0.3820(min) + 0.01354(min)2), and 3.0 mg/kg (minute ventilation = 2.207 – 0.1345 (min) +
0.005549(min)2) equations reveal that the differences in the regression equations are statistically
significant: B0 (F(2, 51) = 99.69, p<0.0001), B1 (F(2, 51) = 14.57, p<0.0001), B2 (F(2, 51) = 7.687,
p<0.0012). Comparison of r2 values (0.03 mg/kg = 0.9231, 0.3 mg/kg = 0.9723, 3.0 mg/kg =
0.4061) show that time accounted for 92.31% and 97.23% of the variance in minute ventilation
for the 0.03 mg/kg and 0.3 mg/kg doses, respectively. However, only 40.61% of the variation in
minute ventilation can be accounted for by the variation in time for the 3.0 mg/kg dose. Given
that this analysis focuses on the first 20 minutes post-injection, the lower r2 for the 3.0 mg/kg
dose could suggest that the onset of OIRD is less dependent on time.
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Figure 3. Fentanyl caused a dose-dependent differences in onset of respiratory depression.
Second-order regression equations visualizing the effect of fentanyl on minute ventilation for the
0.03 mg/kg, 0.3 mg/kg, and 3.0 mg/kg dose of fentanyl plotted as a function of time. Each data
point represents the average minute ventilation for n=12 subjects over a particular 60-second
recording period for the first 20 minutes post-injection. All parameters B0, B1, and B2 were
significantly different between the regression lines, suggesting differences in the onset of OIRD
as a function of dose.
PFC Neostigmine Administration Mitigated OIRD
Behavioral observations of mice were made following administration of each treatment
condition. Mice behaviors in the chamber were largely identical to the descriptions noted from
the concentration-response study. Observations made following the PFC saline control
conditions support the interpretation that the intracerebral microinjection procedure itself does
not cause any behavioral confounds. Behavioral changes noted in mice following microinjection
of neostigmine, however, suggest a potential cholinergic drug effect. All mice exhibited
heightened activity in the chamber, characterized by a faster pacing around the chamber and
increased twitch-like movements. Although this effect waned over the course of the postinjection recording period, one mouse was observed to exhibit the same hyper motoric effect up
to 8 hours post-injection. Histology pending, these differences could be explained by differences
in microinjection site. However, no subjects exhibited signs of distress, discomfort, or harm, and
the experiments proceeded accordingly.
In the first 15 minutes post-injection, neostigmine microinjected into the PFC attenuated
respiratory depression caused by fentanyl. Figure 4 shows vertical scatterplots with median and
interquartile range (IQR) for frequency, tidal volume, minute ventilation, and duty cycle across 5
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conditions: 1 = (IP saline + PFC saline), 2 = (IP 0.1 mg/kg fentanyl + PFC saline), 3 = (IP 0.1
mg/kg fentanyl + PFC neostigmine), 4 = (IP 0.3 mg/kg fentanyl + PFC saline), 5 = (IP 0.3 mg/kg
fentanyl + PFC neostigmine). Comparing conditions 2 and 3 showed that IP 0.1 mg/kg fentanyl
+ PFC neostigmine caused, on average, a 26.9% increase in mean frequency (Cohen’s d = 0.68)
and a 44.3% increase in mean VE (Cohen’s d = 0.74) relative to IP 0.1 mg/kg fentanyl + PFC
saline. The ability of PFC neostigmine to mitigate OIRD diminished with a higher dose of
fentanyl. The calculated effect sizes correspond to a relative moderate effect. Comparing
conditions 5 and 6 showed that IP 0.3 mg/kg fentanyl + PFC neostigmine caused, on average, a
19.6% increase in mean frequency (Cohen’s d = 0.47) and a 7.4% increase in mean VE (Cohen’s
d = 0.14) relative to IP 0.3 mg/kg fentanyl. The calculated effect sizes correspond to a relatively
small effect. Due to a non-normal distribution, nonparametric statistical tests were used to
evaluate differences across conditions. However, Friedman test revealed that observed
differences between treatment conditions were not significant for any breathing measures:
frequency (p = 0.4421), tidal volume (p = 0.1435), minute ventilation (p = 0.4790), and duty
cycle (p = 0.3703), likely because of a small sample size.
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Figure 4. Vertical scatterplots with median (horizontal bar) and interquartile range (vertical bar)
for frequency (A), tidal volume (B), minute ventilation (C), and duty cycle (D) across 5
treatment conditions. Each data point represents the 15-minute post-injection average value for a
single subject. With a sample of n=4, Inferential statistics did not reveal a significant main effect
between treatment groups.
Poincaré plots are useful for visualizing the differences in breathing variability across
treatment conditions. Figure 5 shows Poincaré plots comparing minute ventilation variability
between conditions: (a) IP 0.1 mg/kg fentanyl + PFC saline VS IP 0.1 mg/kg fentanyl + PFC
neostigmine (b) IP 0.3 mg/kg fentanyl + PFC saline VS IP 0.3 mg/kg fentanyl + PFC
neostigmine. WBP data were averaged every 1 min for the first 15 minutes. The x-coordinate of
each data point represents the average minute ventilation for a particular 1-minute interval (n)
averaged across all subjects, and the y-coordinate represents the average minute ventilation for
the subsequent 1-minute interval (n+1). For example, if the x-coordinate of a data point is the
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minute ventilation average for min 1, the y-coordinate is the minute ventilation average for min
2. The dispersion of points is an indicator of variability, where greater dispersion of points is
associated with greater variability. In figure 5a, the distribution of points appears to be greater
for the 0.1 Fent + Neo condition, suggesting that neostigmine increased breathing variability.
Figure 5b shows that the cluster of points for the 0.3 Fent + Neo and 0.3 Fent + Sal condition
overlap, and that neostigmine did not increase breathing variability for the 0.3 mg/kg fentanyl
condition as was observed in the 0.1 mg/kg condition. These observations are consistent with the
raw data, where the ability of neostigmine to attenuate OIRD was diminished for higher doses of
fentanyl.
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Figure 5. Poincaré plots visualizing breathing variability across treatment conditions for min 115 post-injection. Each data point represents the average minute ventilation across all subjects
for a particular 60-second period (x coordinate), plotted against the average minute ventilation of
the subsequent 60-second period (y coordinate). For the 0.1 mg/kg dose of fentanyl, PFC
neostigmine appears to increase breathing variability (A), as seen by a greater distribution of data
points. For the 0.3 mg/kg dose of fentanyl, PFC neostigmine does not appear to increase
breathing variability (B).
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Results from Poincaré analyses show that breathing variability is differentially altered
across treatment conditions. Breathing variability was quantified by short term variability,
known as standard deviation 1 (SD1), and long-term variability, known as standard deviation 2
(SD2). SD1 calculates the average variability in Mvb between each 60-second period, and SD2
calculates Mvb variability across the entire 15-minute period. Figure 6 shows vertical
scatterplots with median and IQR bars to characterize SD1 and SD2 between each treatment
condition. Following administration of the 0.1 mg/kg dose of fentanyl, PFC neostigmine caused,
on average, a 29.5% increase in SD1 for minute ventilation (Cohen’s d = 1.2) and a 9.45%
increase in SD2 for minute ventilation (Cohen’s d = 0.7) compared to the saline condition. The
Cohen’s d statistics correspond to a large effect for SD1 and medium effect for SD2.
Neostigmine did not increase SD1 or SD2 for minute ventilation following administration of the
0.3 mg/kg dose of fentanyl, consistent with previous observations. Nonparametric statistics via
the Friedmann test revealed a significant main effect of treatment condition on minute ventilation
SD1 (p = 0.0022) but not minute ventilation SD2 (p = 0.8946). Despite a significant main effect,
Tukey’s post-hoc comparisons were inconclusive on which treatment conditions were
significantly different in minute ventilation SD1.
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Figure 6. Comparison of minute ventilation short-term variability (SD1) and long-term
variability (SD2) across treatment condition, with horizontal bar representing median and
vertical bar representing IQR. Each data point represents the average SD1 or SD2 across all
subjects for each treatment condition. Although nonparametric statistics found significant
differences between treatment groups in minute ventilation SD1, post-hoc comparisons were
inconclusive. No significant differences between treatment groups were found for minute
ventilation SD2.
Regression analyses revealed that 4.8 ng of PFC Neo slowed the onset of OIRD caused
by 0.1 mg/kg fentanyl. Minute ventilation was quantified during the initial 15 minutes after PFC
Neo microinjection, and a simple linear regression was used to model the min 1-5, min 6-10, and
min 11-15 post-injection separately, as well as the entire 15 min (Fig 7). Given that PFC neo
exerted little to no effect in the 0.3 mg/kg fentanyl conditions, analyses focused on 0.1 mg/kg
fentanyl conditions. During min 1-5 after PFC injection (Fig 7a), comparison of the slopes for
PFC Sal (minute ventilation = -0.1537(min) + 3.38; r2 = 0.5972) and PFC Neo (minute
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ventilation = -0.3207(min) + 5.1; r2 = 0.8408) equations show that there are no significant
differences in slopes of the regression equations for the first 5 minutes (F(1,6) = 2.363, p =
0.1752). For PFC Neo, variance in time accounted for 84% of the variance in minute ventilation,
whereas time accounted for 60% of the variance in minute ventilation after PFC saline.
Comparison of the slopes for PFC Sal (minute ventilation = -0.1165(min) + 3.803; r2 = 0.7920)
and PFC Neo (minute ventilation = 0.03205(min) + 3.217; r2 = 0.2689) found significant
differences between slope during min 6-10 after PFC injection (F(1,6) = 2.363, p = 0.0180) (Fig
7b). During the 6-10 min after PFC neo injection, time only accounted for 27% of the variance in
minute ventilation, likely due to drug effect and neostigmine diffusing away from the PFC. For
min 11-15 after injection, the slopes of the regression lines remained significantly different
between PFC Sal (minute ventilation = -0.04723(min) + 3.556; r2 = 0.4906) and PFC Neo
(minute ventilation = 0.06466(min) + 2.694; r2 = 0.5711) (F(1,6) = 6.885, = 0.0394). Finally,
analysis of regression equations for the first 15 minutes found significant differences in slope
between PFC Sal (minute ventilation = -0.009748(min) + 2.991) and PFC Neo (minute
ventilation = 0.06211(min) + 4.213) (F(1,26) = 2.363 p = 0.0434). These analyses support the
interpretation that PFC neostigmine diminishes the effect of fentanyl on breathing by altering the
onset and time course trajectory of respiratory depression.
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Figure 7. Regression equations comparing differences in on the onset of OIRD between the IP
Fent + PFC Sal and IP Fent + PFC Neo conditions for min 1-5 (A), min 6-10 (B), min 11-15 (C),
and min 1-15 (D) post-injection. Each data point represents the average minute ventilation for a
particular 60-second recording period over all subjects. The slopes of the regression equations
were not significantly different for min 1-5 but were significantly different for min 6-10 and min
11-15. Additionally, the slopes of the regression equations for min 1-15 were significantly
different.
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Effects of PFC Carbachol on Breathing
Although no abnormalities in behavior were noted in subjects following administration of
the 1 mM dose of carbachol, an adverse reaction occurred in both mice following the
administration of the 10 mM dose of carbachol. Initially, mice exhibited heightened ambulation
that were distinct from observations in previous studies. At approximately 5-10 minutes postinjection, both mice begin to show seizure-like activity, with frequent convulsions and
hyperventilation. Mice alternated between episodes of normal behavior and seizure activity. EEG
waves during the seizure episodes showed abnormally high amplitude, higher than that of delta
waves, and lower frequency than beta waves. One mouse was observed to exhibit a red, vessellike discoloration that circled its entire snout. Mice were euthanized before completion of data
collection for the experiment to ensure humane treatment of subjects.
Data collected from the 1.0 mM PFC carbachol experiment were analyzed. Figure 8
compares the average VE for min 1-15 post-injection across treatment conditions. Compared to
the IP Sal + PFC Sal condition, 1 mM PFC Carb increased minute ventilation, on average, by
47.53% (Cohen’s d = 1.0). The calculated effect size corresponds to a large effect. No inferential
statistics were run due to an unequal sample size between groups. Given that the 10 mM dose of
PFC carbachol was lethal with adverse effects on B6 mice, future studies using PFC carbachol
on B6 mice should initially focus on the 1.0 mM dose.
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Figure 8. Results of pilot study testing effects of PFC Carb on breathing. Vertical scatterplots
showing minute ventilation during min 1-15 after administration of 1mM PFC Carb compared to
IP Sal + PFC Sal. Each data point represents the average minute ventilation over 15 minutes for
one subject. No inferential statistics were run.
DISCUSSION
Three main findings emerged from this study. First, fentanyl significantly depressed
breathing in a dose-dependent manner in unrestrained, awake B6 mice. Second, preliminary data
show that PFC neostigmine has the potential to mitigate respiratory depression caused by
systemically administered fentanyl. Third, regression analyses show that PFC neostigmine
significantly slowed the onset of OIRD. These findings are discussed in the context of two major
themes. First, the idea that cholinergic transmission in the PFC contributes to the wakeful
stimulus for breathing. Second, the potential for cholinergic drugs as a countermeasure for
OIRD. Finally, limitations of the studies are discussed.
Fentanyl caused respiratory depression in a dose-dependent manner
My concentration response study shows that increasing the dosage of fentanyl diminishes
respiratory frequency (Fig. 2a) and minute ventilation (Fig. 2c) but increases tidal volume (Fig.
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2b) and duty cycle (Fig. 2d). To the best of my knowledge, there are no previously published
studies on the dose-dependent effects of fentanyl on breathing in awake, unrestrained B6 mice
breathing room air. Previous dose-response studies have manipulated the concentration of CO2
(Hill et al., 2018) or measured breathing during an anesthetic state (Sakuraba et al., 2009). Thus,
this study fills a critical void left in the literature characterizing dose-dependent changes in
breathing in wild-type mice under normal conditions.
My concentration response data reveal an inverse relationship between the measures of
breathing. Higher doses of fentanyl reliably decreased average frequency and minute ventilation
but also increased average tidal volume and duty cycle. Duty cycle is defined as the proportion
of time spent in the inspiratory phase of breathing during one breath cycle. Prolonged inspiration
caused by opioids can also been seen in the waveforms of respiratory traces (Hill et al., 2018)
and allows for an increased tidal volume to compensate for a decrease in the number of
respirations. However, Bachmutsky and colleagues identify a “pause” phase following the
inspiratory phase and preceding the expiratory phase that is characterized by little to no airflow
(Bachmutsky et al., 2020). This finding potentially explains why the increase in tidal volume
does not fully compensate for the decrease in frequency, as evidenced by the reduction in per
gram body weight minute ventilation. Increases in inspiratory duty cycle are also observed in
patients with sleep-disordered breathing (SDB) (Schneider et al., 2009). These compensatory
behaviors are also indicative of a loss of the volitional control of breathing and the drive to
breathe, both of which are vital for psychological well-being (Zaccaro et al., 2018) and patient
stability (Vaporidi et al., 2020). Thus, given the relationship between opioid use, OIRD, and
SDB (Farney, Walker, Cloward, & Rhondeau, 2003; Jungquist, Card, Charchaflieh, Gali, &
Yilmaz, 2018), these findings highlight the importance of sleep-wake regulation in managing
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state-dependent disorders of breathing. For example, patients receiving opioids are more likely to
exhibit respiratory depression (Nagappa, Weingarten, Montandon, Sprung, & Chung, 2017) or
central sleep apnea (Farney et al., 2003) when they are asleep compared to when they are awake.
The importance of sleep-wake mechanisms is further evidenced by findings that opioid
administration is associated with EEG changes in patients (Nagappa et al., 2017) and rodents
(Montandon & Horner, 2019; Osman et al., 2005). These studies show that opioids cause a
dissociated state of consciousness characterized by a reduction of EEG waves associated with
wakefulness and an increase in EEG waves such as delta. They also support the need for more
studies quantifying the relationship between opioids, breathing, and EEG.
Fentanyl-induced respiratory depression remains unique in that it is the only opioid
known to cause the “Wooden Chest Syndrome”, (Hamilton & Cullen, 1953; Pergolizzi Jr,
Webster, Vortsman, Ann LeQuang, & Raffa, 2021), which is characterized by laryngospasm and
chest wall and diaphragm rigidity. Onset of the Wooden Chest Syndrome complicates ventilation
efforts (Çoruh, Tonelli, & Park, 2013) and has been observed even in low fentanyl doses
(Ackerman, Phero, & Theodore, 1990). The mechanisms of the Wooden Chest Syndrome are not
fully understood. However, it is believed to be mediated within the nucleus raphe pontis and
caudate nucleus (Freye & Kuschinsky, 1976; Sokoll, Hoyt, & Gergis, 1972). Several
neuroanatomical studies show mutual projections between the PFC and the nucleus raphe and
caudate (Celada, Puig, Casanovas, Guillazo, & Artigas, 2001; Geddes et al., 2016; Nakamura,
Ozawa, & Koike, 2020; Ulrich, Keller, & Grön, 2016), highlighting the importance of
identifying the neurochemical mechanisms through which the PFC modulates respiration.
Additionally, the Wooden Chest Syndrome also demonstrates the importance of pharmacological
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studies like this one and encourages future studies characterizing the nature of respiratory
depression caused by fentanyl.
PFC neostigmine mitigated respiratory depression caused by systemic fentanyl
Although these data are preliminary, they are, to the best of my knowledge, the first to
demonstrate that modulating neurotransmission in a single brain region can attenuate a systemic
opioid effect in awake, unrestrained mice breathing room air. As previously discussed, fentanylinduced respiratory depression is the most severe form of OIRD (Hill, Santhakumar, Dewey,
Kelly, & Henderson, 2020), where respiratory arrest can occur in as little as 5 minutes after
fentanyl administration (Topacoglu, Karcioglu, Cimrin, & Arnold, 2005). My emerging data also
shows that PFC Neo significantly slowed the onset of fentanyl-induced respiratory depression
(figure 7). The finding that cholinergic transmission can mitigate OIRD is particularly significant
because there are no respiratory neurons in the PFC that generate the respiratory rhythm. Thus,
these results suggest that the PFC modulates breathing by projecting to the brainstem respiratory
network. The pre-Böt contains cholinergic receptors (Shao & Feldman, 2009), and the
respiratory motoneurons also receive cholinergic input (Woolf & Butcher, 1989). Modulating
cholinergic transmission in these regions had direct effects on respiratory rhythm and tonic
output (Shao & Feldman, 2009), where increased cholinergic transmission stimulated respiratory
output. Thus, my data are consistent with evidence documenting the association between
cholinergic transmission in the PFC and opioids (Osman et al., 2005) and respiration.
Additionally, they agree with studies showing that PFC dysregulation is implicated in drug
addiction (Goldstein & Volkow, 2011).
The concept of a wakefulness stimulus for breathing was first characterized after the
observations that breathing was slowed during slow-wave sleep, and that sleep apnea often
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occurred after the loss of wakefulness (Fink, Hanks, Ngai, & Papper, 1963; John Orem, Netick,
& Dement, 1977). Understanding the neuronal mechanisms underlying this wakefulness stimulus
is relevant for OIRD because electrophysiological data show that antinociceptive doses of
opioids alter EEG-defined states of consciousness in mice (O'Brien et al., 2021). These data
suggest the interpretation that respiratory depression from opioids occur due to altered
consciousness, which suppresses the wakefulness stimulus for breathing. Although this
wakefulness stimulus is not fully understood, previous studies have localized this wakefulness
stimulus to the activity of the reticular activating system (Horner, 2001), which influences upper
airway muscle activity (J. Orem, Lovering, Dunin-Barkowski, & Vidruk, 2002). My findings not
only extend previous studies from our laboratory (Glovak et al., 2021) but also demonstrate that
the PFC is an important brain region contributing to this wakefulness stimulus by enhancing
cholinergic transmission.
It is important to highlight the antagonistic relationship between the PFC and the pontine
reticular formation (PRF), where cholinergic transmission yields opposite effects in both brain
regions. Cholinergic transmission in the PFC promotes wakefulness, but cholinergic transmission
in the PRF promotes REM sleep (Baghdoyan & Lydic, 2012). Acetylcholine release in the PFC
can be decreased by cholinergic transmission in the PRF (Demarco, Baghdoyan, & Lydic, 2004).
Enhancing acetylcholine release in the PRF is associated with respiratory depression (Lydic &
Baghdoyan, 1993). These data support past studies (Lydic, 1996) and demonstrate the
importance of brain mechanisms in modulating sleep/wake states and regulation of respiration.
These data also support the need to better understand brain-region specific effects of
neurotransmission on behavioral states.
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Limitations
There are some limitations of the present studies. First, these studies had a small sample
size and only used wild-type, adult, male B6 mice. Biological sex modulates the effects of
opioids on breathing (Albert M. Dahan, Sarton, Teppema, & Olievier, 1998), and therefore, it is
unknown if the effects of PFC Neo on OIRD is sexually dimorphic. Given that the extent to
which opioids alter breathing is determined by other factors such as leptin status (Glovak et al.,
2021), they encourage future studies to investigate whether the ability of PFC Neo to modulate
breathing is dependent on these factors. My studies did not analyze the effects of opioids or PFC
Neo on chemoreception, but it is important to acknowledge that opioids depress chemosensitivity
(Kirby & McQueen, 1986; K. T. Pattinson, 2008). Additionally, the exact mechanisms and
descending pathways from the PFC to the brainstem respiratory network are unclear. These
studies were primarily aimed at understanding how altering neurochemistry modulates breathing,
but they serve as an important first step towards identifying such mechanisms.
CONCLUSION
The studies in this psychology honors thesis are the first, to my knowledge, to
characterize the dose-dependent effect of fentanyl on respiration in awake, unrestrained male B6
mice breathing room air. Preliminary data also demonstrate that cholinergic transmission in the
PFC can mitigate respiratory depression caused by systemically delivered opioids. Higher doses
of fentanyl significantly decreased respiratory frequency and minute ventilation, increased tidal
volume and duty cycle, and resulted in a faster onset of respiratory depression. Microinjection of
neostigmine into the PFC attenuates the effects of fentanyl on frequency and minute ventilation
while significantly slowing the onset of OIRD in the first 15 minutes. These results extend my
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previous data showing that breathing of intact, awake mice is stimulated by PFC Neo and
support the interpretation that cholinergic transmission in the PFC contributes to the wakefulness
stimulus for breathing.
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